| Go to the patient area
BTI Training Center BTI Channel Contact | Clients area
This website may contain Scientific Information on unapproved use of approved medical product communications.

Ophthalmology

The various formulations available through ENDORET® Technology provide the safe, effective, and reproducible solution that ophthalmologists have sought for treating a range of ocular pathologies.

Know more
Home >
Ophthalmology >

Most Popular Articles

Discover the most popular scientific articles about ENDORET® Technology in the field of Ophthalmology.

Efficacy of Plasma Rich in Growth Factors for the Treatment of Dry Eye
Efficacy of Plasma Rich in Growth Factors for the Treatment of Dry Eye
✏ Abstract ⎯ Dry eye disease (DED)
Efficacy of Plasma Rich in Growth Factors for the Treatment of Dry Eye
López-Plandolit S, Morales MC, Freire V, Grau AE, Durán JA. Cornea. 2011 Dec;30(12):1312-7.
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
✏ Abstract ⎯ Preclinical publications on the anterior pole
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
Anitua E, de la Fuente M, Muruzábal F, Merayo-Lloves J. Cornea. 2021 Jan;40(1):107-112.
Plasma Rich in Growth Factors as a Therapeutic Agent for Persistent Corneal Epithelial Defects
Plasma Rich in Growth Factors as a Therapeutic Agent for Persistent Corneal Epithelial Defects
✏ Abstract ⎯ Persistent epithelial defects (PED)
Plasma Rich in Growth Factors as a Therapeutic Agent for Persistent Corneal Epithelial Defects
López-Plandolit S, Morales MC, Freire V, Etxebarría J, Durán JA. Cornea. 2010 Aug;29(8):843-8.

Scientific Articles in Ophthalmology

Explore the complete collection of scientific publications from BTI Biotechnology Institute regarding ENDORET® Technology and its applications in Ophthalmology.

Plasma Rich in Growth Factors as a Therapeutic Agent for Persistent Corneal Epithelial Defects
✏ Abstract ⎯ Persistent epithelial defects (PED)
Plasma Rich in Growth Factors as a Therapeutic Agent for Persistent Corneal Epithelial Defects
López-Plandolit S, Morales MC, Freire V, Etxebarría J, Durán JA. Cornea. 2010 Aug;29(8):843-8.
Efficacy of Plasma Rich in Growth Factors for the Treatment of Dry Eye
✏ Abstract ⎯ Dry eye disease (DED)
Efficacy of Plasma Rich in Growth Factors for the Treatment of Dry Eye
López-Plandolit S, Morales MC, Freire V, Grau AE, Durán JA. Cornea. 2011 Dec;30(12):1312-7.
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
✏ Abstract ⎯ Preclinical publications on the anterior pole
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
Anitua E, de la Fuente M, Muruzábal F, Merayo-Lloves J. Cornea. 2021 Jan;40(1):107-112.
Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study.
Alvarado-Villacorta R, Merayo-Lloves J, Sánchez-Ávila RM, Alfonso-Bartolozzi B, Lisa C, Fernández-Vega-Cueto L, Alfonso JF, Anitua E. Ophthalmol Ther. 2025 Sep;14(9):2253-2281.
View abstract
Plasma rich in growth factors as a treatment for ocular fundus diseases: Mapping current applications and future directions.
Anitua E, Reparaz I, Alkhraisat MH. Biomed Pharmacother. 2025 Oct;191:118440.
View abstract
Advances in Platelet Rich Plasma-Derived Extracellular Vesicles for Regenerative Medicine: A Systematic-Narrative Review
Anitua E, Troya M, Falcon-Pérez JM, López-Sarrio S, González E, Alkhraisat MH. Int J Mol Sci. 2023 Aug 22;24(17):13043.
View abstract
Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus
Anitua E, de la Sen-Corcuera B, Orive G, Sánchez-Ávila RM, Heredia P, Muruzabal F, Merayo-Lloves J. Expert Opin Biol Ther. 2022 Jan;22(1):31-45.
View abstract
Galenic validation of plasma rich in growth factors eye drops
Anitua E, Muruzábal F, Riestra A, De la Fuente M, Merayo-Lloves J. Farm Hosp. 2019 Mar 1;43(2):45-49.
View abstract
Platelet rich plasma in ocular surface
Riestra AC, Alonso-Herreros JM, Merayo-Lloves J. Arch Soc Esp Oftalmol. 2016 Oct;91(10):475-90.
View abstract
Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases
Anitua E, Muruzabal F, de la Fuente M, Merayo J, Durán J, Orive G. Curr Eye Res. 2016 Jul;41(7):875-82.
View abstract
Closing regulatory gaps: new ground rules for platelet-rich plasma
Anitua E, Prado R, Orive G. Trends Biotechnol. 2015 Sep;33(9):492-5.
View abstract
Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies
Anitua E, Muruzabal F, Tayebba A, Riestra A, Perez VL, Merayo-Lloves J, Orive G. Acta Ophthalmol. 2015 Dec;93(8):e605-14.
View abstract
First Case Report of Successful Use of ILM Peeling, Inverted Flap and PRGF-Endoret® in Bilateral Macular Hole in Behçet's Disease
Bertolani Y, Angrill Valls J, Goncharova T, Kirkegaard-Biosca E, Distefano L, Garcia-Arumi C, Garcia-Arumi J. Ocul Immunol Inflamm. 2025 Apr 3:1-5.
View abstract
Successful use of PRGF-endoret® and ILM peeling for full thickness macular hole in MacTel type 2: A case report and review of literature
Bertolani Y, Arnaiz-Camacho A, Fernández-Engroba J, García-Arumí J, Zapata MÁ. Eur J Ophthalmol. 2025 Mar;35(2):NP33-NP38.
View abstract
RWC Update: Intraoperative Fluorescein Angiography, Plasma Rich in Growth Factor as Adjuvant to Vitrectomy in High Myopic Retinal Detachment Associated with Full-Thickness Macular Hole, Giant Tear of the Retinal Pigment Epithelium
Sharma A, Wu L, Bloom S, Stanga P, Figueroa M, Govetto A, Mirajkar A, Nagpal M, Mehrotra N, Sharma A, Rezaei K. OSLI Retina. 2023 May;54(5):259–264.
View abstract
Plasma Rich in Growth Factors in Macular Hole Surgery
Sánchez-Ávila RM, Robayo-Esper CA, Villota-Deleu E, Fernández-Vega Sanz Á, Fernández-Vega González Á, de la Sen-Corcuera B, Anitua E, Merayo- Lloves J. Clin Pract. 2022 Jan 10;12(1):57-69.
View abstract
Plasma rich in growth factors as treatment for a full-thickness macular hole due to macular telangiectasia type 2
Rangel CM, Blanco NA, Pedraza-Concha A, Gomez MA, Parra MM, Arias JD. Arch Soc Esp Oftalmol (Engl Ed). 2021 Feb 21:S0365-6691(20)30491-3.
View abstract
Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes
Figueroa MS, Mora Cantallops A, Virgili G, Govetto A. Eur J Ophthalmol. 2021 Sep;31(5):2612-2620.
View abstract
Plasma Rich in Growth Factors for Persistent Macular Hole: A Pilot Study
Arias JD, Hoyos AT, Alcántara B, Sanchez-Avila RM, Arango FJ, Galvis V. Retin Cases Brief Rep. 2022 Mar 1;16(2):155-160.
View abstract
Treatment of recurrent myopic macular hole using membrane of plasma rich in growth factors
Sánchez-Ávila RM, Fernández-Vega González Á, Fernández-Vega Sanz Á, Merayo-Lloves J. Int Med Case Rep J. 2019 Jul 12;12:229-233.
View abstract
Plasma Rich in Growth Factors Promotes Autophagy in ARPE19 Cells in Response to Oxidative Stress Induced by Blue Light
Suárez-Barrio C, Del Olmo-Aguado S, García-Pérez E, Fernández-Vega-Cueto L, Fernández-Vega Cueto A, Baamonde-Arbaiza B, Fernández-Vega L, Merayo-Lloves J. Biomolecules. 2021 Jun 28;11(7):954.
View abstract
The Effect of Plasma Rich in Growth Factors on Microglial Migration, Macroglial Gliosis and Proliferation, and Neuronal Survival
Ruzafa N, Pereiro X, Fonollosa A, Araiz J, Acera A, Vecino E. Front Pharmacol. 2021 Feb 26;12:606232.
View abstract
Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons
Ruzafa N, Pereiro X, Fonollosa A, Araiz J, Acera A, Vecino E. Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons. Front Pharmacol. 2021 Mar 9;12:606275.
View abstract
Plasma Rich in Growth Factors Enhances Cell Survival after in Situ Retinal Degeneration
Suárez-Barrio C, Del Olmo-Aguado S, García-Pérez E, Artime E, de la Fuente M, Muruzabal F, Anitua E, Baamonde-Arbaiza B, Fernández-Vega L, Merayo- Lloves J. Int J Mol Sci. 2020 Oct 9;21(20):7442.
View abstract
Antioxidant Role of PRGF on RPE Cells after Blue Light Insult as a Therapy for Neurodegenerative Diseases
Suárez-Barrio C, Del Olmo-Aguado S, García-Pérez E, de la Fuente M, Muruzabal F, Anitua E, Baamonde-Arbaiza B, Fernández-Vega-Cueto L, Fernández-Vega L, Merayo-Lloves J. Int J Mol Sci. 2020 Feb 4;21(3):1021.
View abstract
Plasma rich in growth factors reduces blue light-induced oxidative damage on retinal pigment epithelial cells and restores their homeostasis by modulating vascular endothelial growth factor and pigment epithelium-derived factor expression
Anitua E, de la Fuente M, Del Olmo-Aguado S, Suarez-Barrio C, Merayo-Lloves J, Muruzabal F. Clin Exp Ophthalmol. 2020 Aug;48(6):830-838.
View abstract
Early epithelial recovery with blood-based therapy in Meesmann dystrophy: Confocal microscopy and clinical correlation
Fernández-Vega-Cueto L, Alfonso-Bartolozzi B, Alvarado-Villacorta R. J Fr Ophtalmol. 2024 Jun;47(6):104184.
View abstract
Plasma rich in growth factors (PRGF) technology as adjuvant to Ab Externo trabeculectomy
Pereira JM, Matos AC. Int Ophthalmol. 2024 Jul 22;44(1):332.
View abstract
Safety of intraoperative autologous plasma incubation of corneal grafts for reducing endothelial cell loss: a pilot study
Mercado C, Hernández C, Lopez-Rojas C, De La Sen-Corcuera B, Anitua E, Barraquer JI, Gutiérrez A, Otero E, Sabater AL. Front Med (Lausanne). 2024 Aug 12;11:1368117.
View abstract
Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy
Rodríguez-Calvo PP, Rodríguez-Uña I, Fernández-Vega-Cueto A, Sánchez-Ávila RM, Anitua E, Merayo-Lloves J. J Clin Med. 2023 May 22;12(10):3604.
View abstract
Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy
Sanchez-Avila RM, Uribe-Badillo EE, Sanz JF, Muruzabal F, Jurado N, Alfonso-Bartolozzi B, Alfonso JF, Baamonde B, Anitua E, Merayo-Lloves J. Medicine (Baltimore). 2021 Jan 22;100(3):e24139.
View abstract
Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases
Sabater AL, Mousa HM, Quinones X, Valenzuela F, Sanchez Avila RM, Orive G, Anitua E, Merayo J, Perez VL. Int Ophthalmol. 2021 Jul;41(7):2347-2358.
View abstract
Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen
Rahhal-Ortuño M, Fernández-Santodomingo AS, Martínez-Rubio C, Barranco-González H, Almor-Palacios I, Rodrigo-Hernández A. Rom J Ophthalmol. 2021 Jul-Sep;65(3):293-295.
View abstract
Plasma Rich in Growth Factors (PRGF) in Transepithelial Photorefractive Keratectomy (TPRK)
Sánchez-González JM, Alonso-Aliste F, Borroni D, Amián-Cordero J, De-Hita-Cantalejo C, Capote-Puente R, Bautista-Llamas MJ, Sánchez-González MC, Rodríguez-Calvo-de-Mora M, Rocha-de-Lossada C. J Clin Med. 2021 Apr 30;10(9):1939.
View abstract
Recurrent pterygium resection associated to fibrin membrane graft: report of two cases
Giralt IM, Bueis AB de los, Zarzuelo A del H, Moreno JVD, Milner RM, Corcuera B de la S. Bras Oftalmol. 2021 Mar;80(2):146–50.
View abstract
Plasma rich in growth factors (PRGF -ENDORET®) to rescue necrotized orbital dermis-fat grafts
Soares RM, Prazeres Lopes S. Orbit. 2022 Oct;41(5):558-562.
View abstract
Membrane of Plasma Rich in Growth Factors in Primary Pterygium Surgery Compared to Amniotic Membrane Transplantation and Conjunctival Autograft
Idoipe M, de la Sen-Corcuera B, Sánchez-Ávila RM, Sánchez-Pérez C, Satué M, Sánchez-Pérez A, Orive G, Muruzabal F, Anitua E, Pablo L. J Clin Med. 2021 Dec 6;10(23):5711.
View abstract
Mini Cleanroom for the Manufacture of Advanced Therapy Medicinal Products (ATMP): Bioengineered Corneal Epithelium
Berisa-Prado S, Vázquez N, Chacón M, Persinal-Medina M, Alonso-Alonso S, Baamonde B, Alfonso JF, Fernández-Vega-Cueto L, Merayo-Lloves J, Meana Á. Pharmaceutics. 2021 Aug 17;13(8):1282.
View abstract
Platelet-rich plasma to rescue an ulcerated orbital dermal fat graft
Chaparro Tapias TA, Díaz Díaz AL, Secondi R, Coy Villamil H, Sánchez España JC. Eur J Ophthalmol. 2019 Nov;29(6):654-658.
View abstract
Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders
Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, Berisa S, Lisa C, Sánchez JA, Muruzabal F, Orive G, Anitua E. Medicine (Baltimore). 2018 Apr;97(17):e0242.
View abstract
Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
Sánchez-Avila RM, Merayo-Lloves J, Fernández ML, Rodríguez-Gutiérrez LA, Rodríguez-Calvo PP, Fernández-Vega Cueto A, Muruzabal F, Orive G, Anitua E. Int Med Case Rep J. 2018 May 1;11:97-103.
View abstract
Subconjunctival PRGF Fibrin Membrane as an Adjuvant to Nonpenetrating Deep Sclerectomy: A 2-Year Pilot Study
Rodríguez-Agirretxe I, Freire V, Muruzabal F, Orive G, Anitua E, Díez-Feijóo E, Acera A. Ophthalmic Res. 2018;59(1):45-52.
View abstract
Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology
Riestra AC, Vazquez N, Chacon M, Berisa S, Sanchez-Avila RM, Orive G, Anitua E, Meana A, Merayo-Lloves J. Ocul Surf. 2017 Apr;15(2):248-256.
View abstract
Acute calcareous corneal degeneration in a patient with chronic graft- versus-host disease
Ruiz MGS, Pérez LA, Picazo CC, Sanz LS, Ontiveros AH, Gregori EE. Rom J Ophthalmol. 2024 Jan-Mar;68(1):53-56.
View abstract
Efficacy of Plasma Rich in Growth Factors (PRGF) in Stage 1 Neurotrophic Keratitis
Ghalibafan S, Osei K, Amescua G, Sabater A. Res Sq [Preprint]. 2023 Jun 30:rs.3.rs-3040369.
View abstract
Recovery of Corneal Innervation after Treatment in Dry Eye Disease: A Confocal Microscopy Study
Barros A, Lozano-Sanroma J, Queiruga-Piñeiro J, Fernández-Vega Cueto L, Anitua E, Alcalde I, Merayo-Lloves J. J Clin Med. 2023 Feb 25;12(5):1841.
View abstract
Initial experiences using plasma rich in growth factors to treat keratoneuralgia
Wang M, Yennam S, Pflugfelder S. Front Med (Lausanne). 2022 Aug 24;9:946828.
View abstract
A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America
Soifer M, Tovar A, Wang M, Mousa HM, Yennam S, Sabater AL, Pflugfelder SC, Perez VL. Ocul Surf. 2022 Jul;25:40-48.
View abstract
Combined therapy of ocular surface disease with plasma rich in growth factors and scleral contact lenses
Wang M, Yennam S, McMillin J, Chen HH, de la Sen-Corcuera B, Hemmati R, Pflugfelder S. Ocul Surf. 2022 Jan;23:162-168.
View abstract
Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases
Sánchez-Ávila RM, Uribe-Badillo E, Fernández-Vega González C, Muruzabal F, de la Sen-Corcuera B, Baamonde B, Quirós LM, Anitua E, Merayo-Lloves J. Vision (Basel). 2021 Jul 2;5(3):34.
View abstract
Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis
de la Sen-Corcuera B, Montero-Iruzubieta J, Sánchez-Ávila RM, Orive G, Anitua E, Caro-Magdaleno M, Merayo-Lloves J. Clin Ophthalmol. 2020 Jun 17;14:1619-1627.
View abstract
Potential Effect of Plasma Rich in Growth Factors-Endoret in Stromal Wound Healing in Additive Surgery
Ibares-Frías L, Gallego-Muñoz P, Orive G, Anitua E, Cantalapiedra-Rodríguez R, Merayo-Lloves J, Martínez-García MC. Ophthalmic Res. 2020;63(2):203-212.
View abstract
Hyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial Defects
Suárez-Barrio C, Etxebarria J, Hernáez-Moya R, Del Val-Alonso M, Rodriguez- Astigarraga M, Urkaregi A, Freire V, Morales MC, Durán JA, Vicario M, Molina I, Herrero-Vanrell R, Andollo N. Int J Mol Sci. 2019 Apr 3;20(7):1655.
View abstract
Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
Sánchez-Avila RM, Merayo-Lloves J, Fernández ML, Rodríguez-Gutiérrez LA, Rodríguez-Calvo PP, Fernández-Vega Cueto A, Muruzabal F, Orive G, Anitua E. Int Med Case Rep J. 2018 May 1;11:97-103.
View abstract
Plasma rich in growth factors for the treatment of rapidly progressing refractory corneal melting due to erlotinib in nonsmall cell lung cancer.
Guarnieri A, Alfonso-Bartolozzi B, Ciufo G, Moreno-Montañés J, Gil-Bazo I. Medicine (Baltimore). 2017 Jun;96(22):e7000.
View abstract
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops
Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, Fernandez-Vega Cueto L, Anitua E, Begoña L, Muruzabal F, Orive G. Int Ophthalmol. 2018 Jun;38(3):1193-1204.
View abstract
Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders
Merayo-Lloves J, Sanchez RM, Riestra AC, Anitua E, Begoña L, Orive G, Fernandez-Vega L. Ophthalmic Res. 2015;55(2):53-61
View abstract
Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease
Lozano-Sanroma J, Barros A, Alcalde I, Sánchez-Ávila RM, Queiruga-Piñeiro J, Fernández-Vega Cueto L, Merayo-Lloves J. Medicina (Kaunas). 2023 May 11;59(5):928.
View abstract
Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease
Lozano-Sanroma J, Barros A, Alcalde I, Alvarado-Villacorta R, Sánchez-Ávila RM, Queiruga-Piñeiro J, Fernández-Vega-Cueto L, Anitua E, Merayo-Lloves J. Diseases. 2024 Apr 11;12(4):76.
View abstract
A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America
Soifer M, Tovar A, Wang M, Mousa HM, Yennam S, Sabater AL, Pflugfelder SC, Perez VL. Ocul Surf. 2022 Jul;25:40-48.
View abstract
Health outcomes and pharmacoeconomic aspects of the treatment with PRGF-Endoret in dry eye syndrome
Gea-Navarrete S, Montero-Hernández M, Gallego-Lago I, Santiuste-Román A, Montesinos-Ortí S, Soler-Company E. OFIL·ILAPHAR. 2021;31(4):357-360.
View abstract
Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases
Sanchez-Avila RM, Merayo-Lloves J, Muruzabal F, Orive G, Anitua E. Eur J Ophthalmol. 2020 Jan;30(1):94-103.
View abstract
Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery
Sanchez-Avila RM, Merayo-Lloves J, Fernandez ML, Rodriguez-Gutierrez LA, Jurado N, Muruzabal F, Orive G, Anitua E. Ophthalmic Res. 2018;60(2):80-86.
View abstract
The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome
Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, Anitua E, Muruzabal F, Orive G, Fernández-Vega L. J Ocul Pharmacol Ther. 2017 Jun;33(5):391-399.
View abstract
Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye
Merayo-Lloves J, Sanchez-Avila RM, Riestra AC, Anitua E, Begoña L, Orive G, Fernandez-Vega L. Ophthalmic Res. 2016 Jul;56(2):68-73.
View abstract
Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders
Merayo-Lloves J, Sanchez RM, Riestra AC, Anitua E, Begoña L, Orive G, Fernandez-Vega L. Ophthalmic Res. 2015;55(2):53-61
View abstract
Stability of freeze-dried plasma rich in growth factors eye drops stored for 3 months at different temperature conditions
Anitua E, de la Fuente M, Muruzábal F, Merayo-Lloves J. Eur J Ophthalmol. 2021 Mar;31(2):354-360.
View abstract
Development and Optimization of Freeze-Dried Eye Drops Derived From Plasma Rich in Growth Factors Technology
Anitua E, de la Fuente M, Alcalde I, Sanchez C, Merayo-Lloves J, Muruzabal F. Transl Vis Sci Technol. 2020 Jun 25;9(7):35.
View abstract
Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technology
Anitua E, Fuente M, Muruzabal F, Merayo-Lloves J. Exp Eye Res. 2021 Feb;203:108402.
View abstract
Role of corneal nerves in ocular surface homeostasis and disease
Labetoulle M, Baudouin C, Calonge M, Merayo-Lloves J, Boboridis KG, Akova YA, Aragona P, Geerling G, Messmer EM, Benítez-Del-Castillo J. Acta Ophthalmol. 2019 Mar;97(2):137-145.
View abstract
Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin
Anitua E, Nurden P, Prado R, Nurden AT, Padilla S. Biomaterials. 2019 Feb;192:440-460.
View abstract
Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)
Anitua E, de la Fuente M, Muruzabal F, Sánchez-Ávila RM, Merayo-Lloves J, Azkargorta M, Elortza F, Orive G. PLoS One. 2018 Oct 12;13(10):e0205073.
View abstract
Serum from plasma rich in growth factors regenerates rabbit corneas by promoting cell proliferation, migration, differentiation, adhesion and limbal stemness.
Etxebarria J, Sanz-Lázaro S, Hernáez-Moya R, Freire V, Durán JA, Morales MC, Andollo N. Acta Ophthalmol. 2017 Dec;95(8):e693-e705
View abstract
PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model
Anitua E, Muruzabal F, de la Fuente M, Riestra A, Merayo-Lloves J, Orive G. Exp Eye Res. 2016 Oct;151:115-21.
View abstract
High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome
Anitua E, Prado R, Azkargorta M, Rodriguez-Suárez E, Iloro I, Casado-Vela J, Elortza F, Orive G. J Tissue Eng Regen Med. 2015 Nov;9(11):E1-12.
View abstract
Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties
Anitua E, Zalduendo M, Troya M, Padilla S, Orive G. PLoS One. 2015 Mar 30;10(3):e0121713.
View abstract
Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts
Anitua E, de la Fuente M, Muruzabal F, Riestra A, Merayo-Lloves J, Orive G. Exp Eye Res. 2015 Jun;135:118-26.
View abstract
Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study
Freire V, Andollo N, Etxebarria J, Hernáez-Moya R, Durán JA, Morales MC. Cornea. 2014 Jun;33(6):614-20.
View abstract
Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop
Anitua E, Muruzabal F, De la Fuente M, Merayo-Lloves J, Orive G. Exp Eye Res. 2014 Feb;119:27-34.
View abstract
The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors
Anitua E, Troya M, Zalduendo MM, Orive G. Ann Anat. 2014 Dec;196(6):423-9.
View abstract
Effects of anti-aggregant, anti-inflammatory and anti-coagulant drug consumption on the preparation and therapeutic potential of plasma rich in growth factors (PRGF)
Anitua E, Troya M, Zalduendo M, Orive G. Growth Factors. 2015 Feb;33(1):57-64.
View abstract
More

Information note

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.
Are you a healthcare professional practicing in the United States?
I am a healthcare professional practicing in the USA I am a healthcare professional practicing outside the USA I am a patient